Clinical Trial Update: Tralokinumab for Dupilumab Failures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tralokinumab for patients with atopic dermatitis who failed dupilumab; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Atopic Dermatitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING